HUCKEL HUBERT E MD 4
4 · CATALYST PHARMACEUTICAL PARTNERS, INC. · Filed May 29, 2012
Insider Transaction Report
Form 4
HUCKEL HUBERT E MD
Director10% Owner
Transactions
- Purchase
Common Stock, par value $0.001 per share
2012-05-24$0.80/sh+125,000$100,000→ 1,304,134 total(indirect: .) - Purchase
Warrants to purchase common stock
2012-05-24+125,000→ 125,000 total(indirect: .)Exercise: $1.04From: 2012-05-30Exp: 2017-05-30→ Common Stock (125,000 underlying)
Holdings
- 824,608
Options to purchase common stock
Exercise: $1.07From: 2011-12-16Exp: 2016-12-16→ Common Stock (824,608 underlying)
Footnotes (2)
- [F1]Securities were sold as units, each consisting of one share of the Issuer's common stock and one five-year warrant to purchase one share of the Issuer's common stock, at a price of $0.80 per unit.
- [F2]Securities are held in a Grantor Retained Annuity Trust, the Trustee of which is Dr. Huckel.